Here is what the page “New Drug Launch Prices Dip Slightly to $257,000 Median in 2023, but Costs Remain High” contains. The median net price for newly launched medicines in the U.S. reached $257,000 in 2023, a slight decrease from the previous year's $300,000, according to a new analysis. While this marks a modest decline, the figure remains exceptionally high, underscoring persistent affordability challenges for patients and the healthcare system.
The analysis, which examined 202 new drug launches, found that prices continue to vary widely by therapeutic area, with oncology and rare disease treatments commanding the highest costs. Despite the dip, the median price is still more than double the level seen just five years ago, highlighting the long-term upward trend in pharmaceutical pricing. Industry experts note that while manufacturers may be exercising some restraint in launch pricing, the overall trajectory remains a concern for payers and policymakers. For the complete material, the listing points back to the source inside the network.